Erratum: Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors (Scientific Reports (2016) 6 (26603) DOI: 10.1038/srep26603);Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mamidala, Rajinikanth ^a,b   Majumdar, Papiya ^c   Jha, Kunal Kumar ^d   Bathula, Chandramohan ^d   Agarwal, Rahul ^d   Chary, M Thirumala ^a   Mazumdar, H K ^c   Munshi, Parthapratim ^d   Sen, Subhabrata ^d  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^b GVK Bio   (India)

^c Indian Institut of Chemical Biology   (India)

^d SHIV NADAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; PROTOZOAL PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CHLOROCEBUS AETHIOPS; CV-1 CELL LINE; ENZYMOLOGY; GENETICS; LEISHMANIA DONOVANI; METABOLISM; MOLECULAR MODEL; VISCERAL LEISHMANIASIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CRYSTALLOGRAPHY, X-RAY; DNA TOPOISOMERASES, TYPE I; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MODELS, MOLECULAR; PROTOZOAN PROTEINS; TOPOISOMERASE I INHIBITORS;

EID: 84971324854     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28120     Document Type: Erratum

References (35)

1. Leishmaniasis, Fact sheet No375: http://www.who.int/mediacentre/factsheets/fs375/en/(2015). (Date of access: 01/02/2015
2. Jean-Moreno, V., Rojas, R., Goyeneche, D., Coombs, G. H., & Walker, J. Leishmania donovani: Differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp. Parasitol. 112, 21-30 (2006
3. Sun, T., & Zhang Y. Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Res. 36, 1654-64 (2008
4. Hamill, Richard J. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity. Drugs 73, 919-934 (2013
5. Dorlo, T. P. C., Balasegaram, M., Beijnen, J. H., & de Vries, P. J. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J. of Antimicrob. Chemother. 67, 2576-2597 (2012
6. Cheesman, S. J. DNA Topoisomerases as targets for antiprotozoal therapy. Parasitol. Today 16, 277-281 (2000
7. Nitiss, J. L. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim. Biophys. Acta 1400, 63-81 (1998
8. Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400, 83-106 (1998
9. Das, B. B., Sen, N., Ganguly, A., & Majumder, H. K. Reconstitution and functional characterization of the unusual bi-subunit type I topoisomerase from Leishmania donovani. FEBS Lett. 565, 81-88 (2004
10. Chaudhuri, P., Majumdar, H. K., & Bhattacharya, S. Synthesis, DNA Binding, and Leishmania Topoisomerase Inhibition Activities of a Novel Series of Anthra[1,2-d]imidazole-6,11-dione Derivatives. J. Med. Chem. 50, 2536-2540 (2007
11. Roy, A., et al. Development of Derivatives of 3,3′ -Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons. PLoS ONE 6, e28493 (2011
12. Böhm, H.-J., Flohr, A., & Stahl, M. Scaffold Hopping. Drug Discov. Today: Technologies 1, 217-224 (2004
13. Teuber. L., et al. Ligands for the benzodiazepine binding site-a survey. Curr. Pharm. Des. 5, 317-343 (1999
14. Andersen, P. H. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur. J. Pharm. 2, 335-347 (1990
15. Kebabian, J. W. Compounds selective for dopamine receptor subtypes. Drug Discov. Today 2, 333-340 (1999
16. Lednicer, D., Tracing the origins of COX-2 inhibitor structures. Curr. Med. Chem. 9, 1457-1461 (2002
17. Trummlitz, G., & Van Ryn, J. Designing selective COX-2 inhibitors: molecular modeling approaches. Curr. Opin. Drug. Discov. Dev. 5, 550-561 (2002
18. Patani. G. A., & LaVoie, E. J. Bioisosterism: A Rational Approach in Drug Design. Chem. Rev. 96, 3147-3176 (1996
19. Ballatore, C., Huryn, D. M., & Smith, A. B. Carboxylic acid (bio)isosteres in drug design. ChemMedChem. 8, 385-395 (2013
20. Isabel, E., et al. Difluoroethylamines as an amide isostere in inhibitors of cathepsin K. Bioorg. Med. Chem. Lett. 21, 920-923 (2011
21. Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789-802 (2006
22. Lavergne, O., et al. Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues. J. Med. Chem. 41, 5410-5419 (1998
23. Pommier, Y., & Cushman, M. The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives. Mol. Cancer Ther. 8, 1008-1014 (2009
24. McKinnon, J. J., Spackman, M. A., & Mitchell, A. S. Novel tools for visualizing and exploring intermolecular interactions in molecular crystals. Acta Crystallogr. Sect. B B60, 627-668 (2004
25. McKinnon, J. J., Jayatilaka, D., & Spackman, M. A. Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. Chem. Commun. 37, 3814-3816 (2007
26. Spackman, M. A., & Jayatilaka, D. Hirshfeld surface analysis. Cryst Eng Comm. 11, 19-32 (2009
27. Pearson, R. D., Romito, R., Symes, P. H., & Harcus, J. L. Interaction of Leishmania donovani Promastigotes with Human Monocyte-Derived Macrophages: Parasite Entry, Intracellular Survival, and Multiplication. Infection and Immunity 32, 1249-1253 (1981
28. Das, B. B., et al. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I. Nucleic Acids Res. 34, 1121-32 (2004
29. Ganguly, A., et al. Leish-Man topoisomerase I: an ideal chimera for unraveling the role of the small subunit of unusual bi-subunit topoisomerase I from Leishmania donovani. Nucleic Acids Res. 34, 6286-97 (2006
30. Chowdhury, S., et al. Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase. Mol. Pharmacol. 80, 694-703 (2011
31. Stewart, L., Ireton, G. C., Parker, L. H., Madden, K. R., & Champoux, J. J. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I. J. Biol. Chem. 271, 7593-601 (1996
32. Sheldrick, G. M. SHELXTL Version 2014/7: Programs for the determination of small and macromolecular crystal structures by single crystal X-ray and neutron diffraction. University of Göttingen Germany. URL http://shelx.uni-ac.gwdg.de/SHELX/index.php (2014
33. Bruker Support APEX3, SAINT and SADABS: Software for data reduction, absorption correction and structure solution. Bruker AXS Inc. Madison, Wisconsin, USA. URL http://www.brukersupport.com/(2015
34. Macrae, C. F., et al. Mercury CSD 2.0 -New Features for the Visualization and Investigation of Crystal Structures J. Appl. Cryst. 39, 453-457 (2006
35. Wolff, S. K., Grimwood, D. J., Mckinnon, J. J., Turner, M. J., Jayatilaka, D., & Spackman, M. A. Crystal Explorer (version 3.1): A Program for Hirshfeld Surface Analysis. University of Western Australia. URL http://hirshfeldsurface.net/(2012